Role summaryas the director, medical affairs, reporting into the sr director, skeletal dysplasia, you will help shape the future of care for individuals with skeletal dysplasias by developing and executing the medical strategy behind infigratinib’s development and launch. You will serve as the scientific voice connecting clinicians, researchers, advocacy groups, and internal teams, ensuring our medical insights drive smart decisions and meaningful progress. Your leadership will influence how qed educates, communicates, and engages the field. This is an opportunity to make a direct and lasting impact on a community with limited therapeutic options today.responsibilitieslead or co-lead advisory boards, symposia, and scientific forums that elevate understanding, spark collaboration, and inform strategybuild trusted partnerships with kols, clinical experts, and the research community to advance scientific and medical insightserve as a key medical reviewer within mlr, guiding compliant and impactful scientific communications and post-marketing commitmentspartner across clinical development, heor, field medical/msl, patient advocacy, and scientific communications to ensure medical strategy and execution are aligned and launch-readyrepresent qed at major scientific and professional meetings, sharing insights and identifying opportunities that support program growthcontribute to medical information initiatives, team training, publication strategy, and evaluation of external collaborationsqualificationsrequired: md, phd or np with 5+ years of post-graduate experience and 3+ years in us medical affairs and/or clinical development (pharma/biotech); clinical experience in pediatric rare disease/skeletal dysplasia is a plusrequired: experienced in pediatric rare diseases with deep understanding of genetics and mechanisms of genetic disease; launch experience preferredrequired: scientific thinker who translates complex science into clear, compelling strategyrequired: collaborative leader who influences without direct authority and thrives in fast-paced environmentsrequired: strong communicator with experience navigating regulatory frameworks relevant to medical affairsrequired: able to travel up to 50% and legally authorized to work in the united statespreferred: pediatric rare disease experience and expertise in skeletal dysplasiaadditional requirementstravel up to 50% for scientific congresses, kol engagements, advisory boards, and key internal meetings
#j-18808-ljbffr